טוען...
Defining “FGF21 Resistance” during obesity: Controversy, criteria and unresolved questions
The term “FGF21 resistance” was first used to describe increased circulating FGF21 levels concomitant to decreased FGF21 receptor complex expression in white adipose tissue of obese mice. Since this initial report, the term has been associated with a wide range of pathological states, including hum...
שמור ב:
| הוצא לאור ב: | F1000Res |
|---|---|
| מחבר ראשי: | |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
F1000 Research Limited
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6020717/ https://ncbi.nlm.nih.gov/pubmed/29983922 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.14117.1 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|